Clinical trial

Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic…

NCT00383643 · Stanford University, Other · Completed

Key facts

NCT number NCT00383643
Title Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia.
Official title Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia: A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group Study.
Lead sponsor Stanford University, Other
Status Completed
Phase Phase 2
Study type Interventional
Conditions Sleep Initiation and Maintenance Disorders
Intervention type Drug
Interventions zolpidem tartrate, sodium oxybate, Matching Placebos
Enrollment 48
Start date May 1, 2006
Primary completion Dec 1, 2009
Completion Dec 1, 2009
First posted Oct 3, 2006
Last update posted Jun 1, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies